| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 05/03/2013 | 18h38 | Zacks | Allergan Reaches 52-Week High - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 04/03/2013 | 17h30 | Zacks | Allergan - MAP Acquisition Update - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 23h23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 23h23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 23h23 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 23h21 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 22h01 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 21h54 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 21h54 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/03/2013 | 15h00 | Business Wire | Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc... | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 20h11 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 19h48 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 12/02/2013 | 19h14 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 11/02/2013 | 23h19 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 11/02/2013 | 20h59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 11/02/2013 | 19h56 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 11/02/2013 | 19h56 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/02/2013 | 21h52 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/02/2013 | 20h15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 08/02/2013 | 19h37 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/02/2013 | 22h59 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 07/02/2013 | 15h00 | Business Wire | Allergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per... | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 20h22 | Dow Jones News | UPDATE: Strong Botox Sales Help Lift Allergan's Profits 16% | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 17h28 | Zacks | AGN Earnings Miss but Guidance Tops - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 16h00 | Dow Jones News | Allergan 4th-Quarter Profit Rose 16% Amid Growing Revenue, Fewer Charges | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 00h08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/02/2013 | 19h08 | GlobeNewswire Inc. | The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceut | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/02/2013 | 17h50 | Zacks | Update on AGN's Acquisition of MAP - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 31/01/2013 | 22h20 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 31/01/2013 | 22h01 | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |